When Reverend Dr Richard Marsh first came to look at St Flannan’s Cathedral with his wife Ro, a misty fog prevailed over ...

Though he might be known for his Western heroics, John Wayne's best performance is actually in The Quiet Man, a movie outside ...

Azenta, Inc. (Nasdaq: AZTA) today announced the appointment of Trey Martin as President of its Multiomics business, effective April 6, 2026. In this role, Mr. Martin will lead the Multiomics ...

THE three cent reduction in agricultural diesel by the Government has been criticised as a “total insult” by a South-East ...

Through its Danaher Business System, Danaher aims for continuous improvement of its scientific technology portfolio by seeking out attractive markets and then making acquisitions to enter or expand ...

Irvine-based health technology and consumer electronics firm Masimo Corp. announced it entered into a definitive agreement to be acquired by healthcare company Danaher Corporation (Danaher). Under the ...

After a turbulent four years of restructuring and proxy battles that shook up its leadership, Masimo Corp. is set to be acquired by Danaher Corp. for $9.9 billion in yet another unexpected twist.

Global life sciences giant Danaher coughed up a pretty penny to buy Masimo this week, spending roughly $10 billion to beef up its diagnostics portfolio. The deal values medical device developer Masimo ...

Danaher, the NYSE-listed biotechnology and diagnostics company, is to acquire Masimo Corporation, the California-based firm best known for its development of optical pulse oximetry devices widely used ...

Danaher (DHR) is acquiring Masimo for $9.9B at $180 per share. This represents a 40% premium. Masimo shares jumped 30.27% toward the deal price. Danaher stock fell 6.09% on integration concerns.